134 related articles for article (PubMed ID: 6804164)
1. Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device.
Heikkilä M; Luukkainen T
Contraception; 1982 Mar; 25(3):279-92. PubMed ID: 6804164
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
3. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
4. Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device.
Heikkilä M
Contraception; 1982 Jun; 25(6):561-72. PubMed ID: 6811195
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
6. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
[TBL] [Abstract][Full Text] [Related]
7. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
8. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
9. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
Andersson K; Odlind V; Rybo G
Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Toivonen J; Luukkainen T; Allonen H
Obstet Gynecol; 1991 Feb; 77(2):261-4. PubMed ID: 1899136
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
13. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
Shaaban MM; Salem HT; Abdullah KA
Contraception; 1985 Dec; 32(6):623-35. PubMed ID: 3937665
[TBL] [Abstract][Full Text] [Related]
14. Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device.
Nilsson CG; Luukkainen T; Diaz J; Allonen H
Contraception; 1982 Apr; 25(4):345-56. PubMed ID: 6809420
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine contraception with levonorgestrel: a comparative randomised clinical performance study.
Nilsson CG; Luukkainen T; Diaz J; Allonen H
Lancet; 1981 Mar; 1(8220 Pt 1):577-80. PubMed ID: 6110819
[TBL] [Abstract][Full Text] [Related]
16. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD.
Heikkilä M; Haukkamaa M; Luukkainen T
Contraception; 1982 Jan; 25(1):41-9. PubMed ID: 6800691
[TBL] [Abstract][Full Text] [Related]
18. Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration.
Chen BA; Reeves MF; Creinin MD; Schwarz EB
Contraception; 2011 Nov; 84(5):499-504. PubMed ID: 22018124
[TBL] [Abstract][Full Text] [Related]
19. Microdose intrauterine levonorgestrel for contraception. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation.
Contraception; 1987 Apr; 35(4):363-79. PubMed ID: 2887401
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]